Rezolute (RZLT) Change in Account Payables (2011 - 2026)
Rezolute's (RZLT) quarterly Change in Account Payables came in at -$587000.0 in Q1 2026, down 117.5% year-on-year from $3.4 million in Q1 2025, and down 212.02% quarter-over-quarter from $524000.0 in Q4 2025.
Rezolute (RZLT) Change in Account Payables (2011 - 2026) Analysis & Trends
Rezolute has disclosed Change in Account Payables across 13 years of filings, most recently posting -$587000.0 for Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$587000.0, down 117.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.3 million (down 210.12% YoY), and the FY2025 annual result was $1.4 million, up 31.21% from the prior year.
- Change in Account Payables came in at -$587000.0 for Q1 2026 at Rezolute, down from $524000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q1 2025 to a low of -$2.8 million in Q1 2022.
- The 5-year median for Change in Account Payables is -$22000.0 (2022), against an average of -$74647.1.
- Across the five-year window, Change in Account Payables plunged 3700.0% in 2023 and surged 3630.53% in 2025, its largest moves.
- Rezolute's Change in Account Payables stood at $1.7 million in 2022, then plunged by 32.89% to $1.2 million in 2023, then decreased by 14.64% to $991000.0 in 2024, then sank by 47.12% to $524000.0 in 2025, then slumped by 212.02% to -$587000.0 in 2026.
- The last three Change in Account Payables figures came in at -$587000.0 (Q1 2026), $524000.0 (Q4 2025), and -$2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -9.42 Mn |
| 10 | Rezolute | 415.38 Mn | 415.38 Mn | - | -587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -587,000.00 |
| Mar 31, 2026 | -587,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | -2.52 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -730,000.00 |
| Jun 30, 2025 | -730,000.00 |
| Mar 31, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 991,000.00 |
| Dec 31, 2024 | 991,000.00 |
| Sep 30, 2024 | -2.19 Mn |
| Sep 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | 853,000.00 |
| Jun 30, 2024 | 853,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |